TellHerDoc review

TellHerDoc for mothers: our verdict

A women-facing telehealth brand selling compounded semaglutide and tirzepatide, with the only public figure a floor: starting at $269 a month. No page prices either molecule specifically, and the formats it advertises — injection, oral, orally disintegrating tablet and a microdose option — are never individually costed, so what you actually pay is unknown until you are through the quiz. ⚠ The banner reading Get $140 Off Today is a discount amount rather than a price, and at least one industry directory has misread it as a $140 introductory rate. It publishes no list of the states it serves and no ongoing rate, so the $269 should be treated as the lowest number the brand is willing to advertise rather than as what a month costs. It runs about $269/month, flat across every dose — a premium to the category, so the extras have to earn it.

We weigh TellHerDoc the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What TellHerDoc costs, in full

• Compounded semaglutide — Not published per molecule: $269/mo
• Compounded tirzepatide — Not published per molecule: $269/mo

For context, the typical ongoing price across our roster is around $179/month, so TellHerDoc sits at the premium end.

TellHerDoc says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.

The medications TellHerDoc prescribes

TellHerDoc prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.

Where TellHerDoc fits — and where it doesn't — for mothers

A good fit if…

• switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.

Look elsewhere if…

• you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
• you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

TellHerDoc is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.